{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:24:21Z","timestamp":1793953461220,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573563"],"award-info":[{"award-number":["82573563"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503795"],"award-info":[{"award-number":["82503795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472956"],"award-info":[{"award-number":["82472956"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202340125"],"award-info":[{"award-number":["202340125"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M750536"],"award-info":[{"award-number":["2024M750536"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX20240082"],"award-info":[{"award-number":["BX20240082"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017633","name":"Shanghai Anti-Cancer Association","doi-asserted-by":"publisher","award":["SACA-AX202211"],"award-info":[{"award-number":["SACA-AX202211"]}],"id":[{"id":"10.13039\/100017633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["24YF2738200"],"award-info":[{"award-number":["24YF2738200"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["24YF2705600"],"award-info":[{"award-number":["24YF2705600"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.canlet.2026.218453","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:37:24Z","timestamp":1774543044000},"page":"218453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Potentiating BSEP-mediated bile acid efflux reverses first-line tyrosine kinase inhibitor resistance in hepatocellular carcinoma"],"prefix":"10.1016","volume":"648","author":[{"given":"Zong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingran","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruobing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218453_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218453_bib2","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218453_bib3","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218453_bib4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/HEP.0000000000001269","article-title":"Critical Update: AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"82","author":"Taddei","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218453_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.annonc.2025.02.006","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Vogel","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218453_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218453_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218453_bib8","first-page":"1602","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218453_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12015-024-10797-1","article-title":"Mitochondria's role in the maintenance of cancer stem cells in hepatocellular carcinoma","volume":"21","author":"Elhinnawi","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.canlet.2026.218453_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4251\/wjgo.v15.i4.617","article-title":"Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy","volume":"15","author":"Feng","year":"2023","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.canlet.2026.218453_bib11","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1158\/0008-5472.CAN-21-2934","article-title":"Caspase-3-Induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma","volume":"82","author":"Mok","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218453_bib12","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1007\/s00432-020-03374-9","article-title":"Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma","volume":"146","author":"Nguyen","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218453_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1033145","article-title":"Deregulated bile acids may drive hepatocellular carcinoma metastasis by inducing an immunosuppressive microenvironment","volume":"12","author":"Xia","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218453_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2022.02.030","article-title":"Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis","volume":"77","author":"Sun","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218453_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1126\/science.adl4100","article-title":"Bile acid synthesis impedes tumor-specific T cell responses during liver cancer","volume":"387","author":"Varanasi","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218453_bib16","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.xphs.2017.05.017","article-title":"Identification of bile acids responsible for inhibiting the bile salt export pump, leading to bile acid accumulation and cell toxicity in rat hepatocytes","volume":"106","author":"Oizumi","year":"2017","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.canlet.2026.218453_bib17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cgh.2020.06.067","article-title":"A high serum level of taurocholic acid is correlated with the severity and resolution of drug-induced liver injury","volume":"19","author":"Tian","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218453_bib18","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00535-013-0833-y","article-title":"Ursodeoxycholic acid stabilizes the bile salt export pump in the apical membrane in MDCK II cells","volume":"49","author":"Kagawa","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218453_bib19","doi-asserted-by":"crossref","first-page":"G175","DOI":"10.1152\/ajpgi.00409.2002","article-title":"Bile acid regulation of hepatic physiology: I. Hepatocyte transport of bile acids","volume":"284","author":"Wolkoff","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.canlet.2026.218453_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/18744672113069990036","article-title":"Bile salt export pump (BSEP\/ABCB11): trafficking and sorting disturbances","volume":"6","author":"Hayashi","year":"2013","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218453_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/03602530903492004","article-title":"Role of the bile salt export pump, BSEP, in acquired forms of cholestasis","volume":"42","author":"Stieger","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.canlet.2026.218453_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101641","article-title":"Regulatory mechanisms of the bile salt export pump (BSEP\/ABCB11) and its role in related diseases","volume":"45","author":"Ren","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218453_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/path.5780","article-title":"Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11-deficient mice","volume":"255","author":"Wang","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218453_bib24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1399-3046.2011.01528.x","article-title":"Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma","volume":"15","author":"Romano","year":"2011","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.canlet.2026.218453_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cpt.2633","article-title":"Quantitative proteomics of hepatic drug-metabolizing enzymes and transporters in patients with colorectal cancer metastasis","volume":"112","author":"Vasilogianni","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2026.218453_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.canlet.2026.218453_bib27","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1194\/jlr.R049437","article-title":"Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades","volume":"55","author":"Hofmann","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.canlet.2026.218453_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107396","article-title":"Ursodeoxycholic acid and cancer: from chemoprevention to chemotherapy","volume":"203","author":"Goossens","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2026.218453_bib29","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/s41467-022-31141-6","article-title":"Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-beta degradation","volume":"13","author":"Shen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218453_bib30","first-page":"2551","article-title":"Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK","volume":"42","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2026.218453_bib31","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1242\/jcs.093781","article-title":"Cortactin in cell migration and cancer at a glance","volume":"125","author":"MacGrath","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2026.218453_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216597","article-title":"A synergistic regulation works in matrix stiffness-driven invadopodia formation in HCC","volume":"582","author":"Zhang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218453_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10735-013-9543-2","article-title":"Synergistic effect of EMS1-shRNA and sorafenib on proliferation, migration, invasion and endocytosis of SMMC-7721","volume":"45","author":"Zhou","year":"2014","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.canlet.2026.218453_bib34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.21037\/hbsn-22-469","article-title":"A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights","volume":"12","author":"Xie","year":"2023","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.canlet.2026.218453_bib35","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1200\/JCO.21.00163","article-title":"Donafenib versus sorafenib in first-line treatment of unresectable or metastatic hepatocellular carcinoma: a randomized, Open-Label, parallel-controlled phase II-III trial","volume":"39","author":"Qin","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218453_bib36","article-title":"Consensus on the lung cancer management after third-generation EGFR-TKI resistance","volume":"53","author":"Zhou","year":"2024","journal-title":"Lancet Reg. Health West. Pac."},{"key":"10.1016\/j.canlet.2026.218453_bib37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","article-title":"EGFR activation limits the response of liver cancer to lenvatinib","volume":"595","author":"Jin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218453_bib38","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.22506","article-title":"Molecular targeted therapies in hepatocellular carcinoma","volume":"48","author":"Llovet","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218453_bib39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1172\/JCI0215968","article-title":"The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II","volume":"110","author":"Wang","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218453_bib40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(03)00228-9","article-title":"Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine","volume":"39","author":"Zollner","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218453_bib41","doi-asserted-by":"crossref","first-page":"D535","DOI":"10.1093\/nar\/gkj109","article-title":"BioGRID: a general repository for interaction datasets","volume":"34","author":"Stark","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218453_bib42","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI61350","article-title":"beta(1)Integrin\/FAK\/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy","volume":"122","author":"Eke","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218453_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/srep34614","article-title":"Identification of the nuclear localisation signal of O-GlcNAc transferase and its nuclear import regulation","volume":"6","author":"Seo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218453_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000301","article-title":"Proteome-wide analysis of chaperone-mediated autophagy targeting motifs","volume":"17","author":"Kirchner","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.canlet.2026.218453_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/cr.2013.153","article-title":"Chaperone-mediated autophagy: roles in disease and aging","volume":"24","author":"Cuervo","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218453_bib46","doi-asserted-by":"crossref","first-page":"D261","DOI":"10.1093\/nar\/gkr1122","article-title":"PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse","volume":"40","author":"Hornbeck","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218453_bib47","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.molmed.2019.05.007","article-title":"PRMTs and arginine methylation: cancer's best-kept secret?","volume":"25","author":"Jarrold","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2026.218453_bib48","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1128\/MCB.25.13.5648-5663.2005","article-title":"Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells","volume":"25","author":"Balint","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218453_bib49","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.7150\/ijbs.107195","article-title":"Regulated cell death in lenvatinib resistance of hepatocellular carcinoma: from molecular mechanisms to therapeutic strategies","volume":"21","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Sci."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:29:41Z","timestamp":1793950181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"alternative-id":["S0304383526002168"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218453","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potentiating BSEP-mediated bile acid efflux reverses first-line tyrosine kinase inhibitor resistance in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218453"}}